Similar articles

• [Glycoprotein P-170, associated with multidrug resistance, in patients with acute leukemia in complete remission].

  Musto P, Carotenuto M. Musto P, et al. Haematologica. 1991 Jun;76 Suppl 3:169-72. Haematologica. 1991. PMID: 1684343 Italian. No abstract available.
• [Multidrug resistance in acute nonlymphoid leukemia].

  Michieli M, Geromin A, Damiani D, Michelutti A, Raspadori D, Masotti A, Russo D, Fanin R, Fasola G, Mallardi F, et al. Michieli M, et al. Haematologica. 1991 Jun;76 Suppl 3:165-8. Haematologica. 1991. PMID: 1684342 Italian. No abstract available.
• The expression of the multidrug transporter P-170 glycoprotein in remission phase is associated with early and resistant relapse in multiple myeloma.

  Musto P, Lombardi G, Matera R, Carotenuto M. Musto P, et al. Haematologica. 1991 Nov-Dec;76(6):513-6. Haematologica. 1991. PMID: 1687943
• [Polychemotherapy in multiple myeloma. The COMPA protocol].

  Vázquez-Villegas V, Delgado Lamas JL, Romero-García F, Rodríguez-Carrillo J, Medina-Ruiz F. Vázquez-Villegas V, et al. Rev Invest Clin. 1989 Oct-Dec;41(4):345-50. Rev Invest Clin. 1989. PMID: 2698501 Review. Spanish.
• [Chemotherapy of multiple myeloma].

  Golenkov AK. Golenkov AK. Sov Med. 1991;(3):43-6. Sov Med. 1991. PMID: 1882290 Review. Russian. No abstract available.